T. Rowe Price Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

T. Rowe Price Associates’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,397,194	Closed	-$1.06B	–	2626
2014 Q4	$1.06B	Sell	10,397,194 -274,384	-3%	-$26.3M	0.23%	109
2014 Q3	$923M	Buy	10,671,578 +392,502	+4%	+$34.8M	0.2%	124
2014 Q2	$927M	Sell	10,279,076 -217,982	-2%	-$16.3M	0.2%	126
2014 Q1	$773M	Buy	10,497,058 +147,454	+1%	+$10.3M	0.17%	153
2013 Q4	$705M	Sell	10,349,604 -261,893	-2%	-$17M	0.16%	157
2013 Q3	$647M	Buy	+10,611,497	New	+$647M	0.16%	167

T. Rowe Price Associates's COV Position: Q1 2015 in Review

T. Rowe Price Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 10,397,194 shares — an estimated $1.06B sold.

T. Rowe Price Associates first reported a position in COV in Q3 2013 and held it in 6 quarters. The position peaked at $1.06B in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

T. Rowe Price Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
T. Rowe Price Associates sold 10,397,194 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $1.06B.
T. Rowe Price Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2013 and held it in 6 quarters.
T. Rowe Price Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.06B in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.